Laurion Capital Management LP Obs Eva Sa Transaction History

Laurion Capital Management LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2018 Feb 14, 2019	SELL	$10.8 - $17.94 $754,185 - $1.25 Million	-69,832 Closed	0 $0
Q3 2018 Nov 13, 2018	SELL	$10.92 - $18.18 $875,434 - $1.46 Million	-80,168 Reduced 53.45%	69,832 $1.26 Million
Q2 2018 Aug 13, 2018	BUY	$10.0 - $17.87 $1.5 Million - $2.68 Million	150,000 New	150,000 $2.27 Million
Q4 2017 Feb 13, 2018	SELL	$8.48 - $12.0 $149,934 - $212,172	-17,681 Closed	0 $0
Q3 2017 Nov 13, 2017	BUY	$6.38 - $8.14 $112,804 - $143,923	17,681	17,681 $144,000

88K

Ticker OBSV
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 84,499,200
Description
ObsEva SA, a biopharmaceutical company, focuses on the development and commercialization of novel therapeutics for women suffering from reproductive health and pregnancy. It is developing Linzagolix, an oral gonadotropin releasing hormone receptor antagonist that is in Phase III clinical trial for the treatment of pain associated with endometrio...

Get notified when there are updates to the investment portfolio of Laurion Capital Management LP, based on Form 13F filings with the SEC.

Stay updated on Laurion Capital Management LP with notifications on news.